# Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

> **NCT05791565** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salbutamol HFA-152a
- **DRUG:** Salbutamol HFA-134a

## Key facts

- **NCT ID:** NCT05791565
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-03
- **Primary completion:** 2023-05-21
- **Final completion:** 2023-05-21
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05791565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05791565, "Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05791565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*